GLP 1 and Other Incretin Analogues Assoc Professor Samantha Hocking

GLP 1 and Other Incretin Analogues Assoc Professor Samantha Hocking

In this lecture, Sam Hocking focuses on incretin-based therapies for managing cardiometabolic diseases, particularly obesity and type 2 diabetes. He discusses the roles of GLP-1 and GIP in insulin regulation and appetite control, and highlights their potential beyond diabetes, including benefits for heart failure and chronic kidney disease.

Hocking evaluates the effectiveness of agents like semaglutide and tizepatide, showcasing significant improvements in glycemic control and weight loss from clinical trials. He also addresses the cardiovascular benefits of these therapies, alongside practical considerations for clinicians in managing side effects and economic accessibility. The lecture concludes with a call for the clinical application of incretin therapies to enhance patient health outcomes.

-------------------------------------------------------------------------------

If you are a General Practitioner who gets invited to dozens of webinars a month. The General Practice Clinical Sessions Podcast is designed for you.

Instead of giving up an evening with your family for a live webinar or your weekend for a conference, you can listen to it here whenever it's convenient, in half the time and while you are commuting, exercising or even walking the dog.

It's the same education, without interrupting your life.

GPs can also earn CPD hours.

Earn Educational Activity (EA) CPD without sacrificing time with your family.

Listen to your Clinical Sessions Podcasts on your commute or while you exercise. Then each week, calculate the amount of time you invest listening and count that as self claimed Educational Activities (EA).

Earn Reviewing Performance (RP) CPD without sacrificing time with your family.

After each podcast, pause for a few minutes and identify and summarise 3 key points relevant to your scope of practice.